Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preventing NSAID-induced gastrointestinal toxicity. Economic considerations, methodological problems and results.

× No keyword cloud information.

28 in total

1. The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis.

Authors: W Bolten; J A Gomes; H Stead; G S Geis
Journal: Br J Rheumatol Date: 1992-11

2. A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis.

Authors: W Verdickt; C Moran; H Hantzschel; A M Fraga; H Stead; G S Geis
Journal: Scand J Rheumatol Date: 1992 Impact factor: 3.641

3. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

Authors: D Y Graham; N M Agrawal; S H Roth
Journal: Lancet Date: 1988-12-03 Impact factor: 79.321

4. [Upper gastrointestinal hemorrhage caused by anti-inflammatory agents].

Authors: C Duhamel; P Czernichow; P Dechelotte; P Ducrotte; E Lerebours; R Colin
Journal: Gastroenterol Clin Biol Date: 1989-03

5. Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium.

Authors: G J Carrin; K E Torfs
Journal: Rev Epidemiol Sante Publique Date: 1990 Impact factor: 1.019

6. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors: C P Armstrong; A L Blower
Journal: Gut Date: 1987-05 Impact factor: 23.059

7. Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.

Authors: J A Melo Gomes; S H Roth; J Zeeh; G A Bruyn; E M Woods; G S Geis
Journal: Ann Rheum Dis Date: 1993-12 Impact factor: 19.103

8. Making sense of NSAID gastropathy and considering the therapeutic options.

Authors: N M Agrawal
Journal: Scand J Rheumatol Suppl Date: 1992

9. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors: R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal: BMJ Date: 1988-10-22

10. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

Authors: S E Gabriel; L Jaakkimainen; C Bombardier
Journal: Ann Intern Med Date: 1991-11-15 Impact factor: 25.391

6 in total

Review 1. Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs.

Authors: H E van Dieten; I B Korthals-de Bos; M W van Tulder; W F Lems; B A Dijkmans; M Boers
Journal: Ann Rheum Dis Date: 2000-10 Impact factor: 19.103

2. The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.

Authors: M J Al; B C Michel; F F Rutten
Journal: Pharmacoeconomics Date: 1996-08 Impact factor: 4.981

Review 6. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.

Authors: R Davis; Y E Yarker; K L Goa
Journal: Drugs Aging Date: 1995-11 Impact factor: 3.923